Author: Dr. David Lowemann

New hope for fight against genetically determined obesity

A large group of people with obesity have a genetic mutation that is causing their obesity. Common treatments for obesity only benefit these people to a limited extent, but now a new study conducted at the University of Copenhagen reveals that they can be treated effectively with the medicine liraglutide, which is a GLP-1 receptor […]

Published on June 1, 2018

Domestic Violence’s Overlooked Damage: Concussion And Brain Injury

Hundreds of survivors of domestic violence have come through the doors of neurologist Glynnis Zieman’s Phoenix clinic in the past three years. “The domestic violence patients are the next chapter of brain injury,” she said. Zieman begins every new patient visit with a simple question: “What are the symptoms you hope I can help you […]

Published on June 1, 2018

Cdk5 Inhibitory Peptide Prevents Loss of Dopaminergic Neurons and Alleviates Behavioral Changes in an MPTP Induced Parkinson’s Disease Mouse Model

Rongni He, Wei Huang, Yaowei Huang, Miaojing Xu, Pingping Song, Yinwei Huang, Huifang Xie, Yafang Hu Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, where he leads the charge in pioneering Self-Enhancement Science for the Success of Society. With […]

Published on June 1, 2018